Notably, high expression level of UCHL5 was significantly correlated with poor PFS in patients with mutant p53 ovarian cancer (Figure 1D) whereas the opposite correlation was observed in patients with wild-type p53 ovarian cancer (Figure 1E). This evidence concerns the gene TP53 and ovarian cancer.